Overview
Our Commitment
Adamas develops new medicines to improve the lives of people affected by chronic neurologic disorders. About Adamas
ADS-5102 in Levodopa-induced Dyskinesia
Why Aminoadamantanes?
We are developing an amantadine therapy for the treatment of levodopa-induced dyskinesia in people with Parkinson's disease. Learn More
Overview
Our Commitment
Adamas develops new medicines to improve the lives of people affected by chronic neurologic disorders. About Adamas